Zofran
Esketamine
Peking University First HospitalPhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Esketamine cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
S-Ketamine Peking University First Hospital | Phase 4 | BBB |
Amitriptyline Beijing Tiantan Hospital | Phase 4 | BBB |
Pregabalin Beijing Tiantan Hospital | Phase 4 | BB |
Bxcl501 Peking University First Hospital | Phase 4 | BB |
SUFENTANYL Peking University First Hospital | Phase 4 | BB |
PROPOFOL Min Su | Early Phase 1 | C |
SUXAMETHONIUM CHLORIDE Min Su | Early Phase 1 | C |
Same molecule, other indications
Zofran is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →